In addition, histochemical analysis indicated that treatment with MLN2238 inhibited in tumor tissues the expression of Ki-67, a cell proliferation marker (Fig. 7d, e), confirming data obtained in vitro using a cell proliferation assay (bromodeoxyuridine (BrdU) assays). The gene discussed is MKI67; the disease is neoplasm.